<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Epinephrine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Epinephrine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Cardiac / Vascular</div>
      <h1>Epinephrine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Epinephrine 1mg/mL Injection 1mL Ampoules</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Cardiac arrest (ACLS)</strong></p>
        <ul>
          <li>1 mg IV/IO every 3–5 minutes</li>
        </ul>
        <p><strong>Anaphylaxis (adult)</strong></p>
        <ul>
          <li>IM 0.5 mg (0.5 mL of 1 mg/mL) into mid-anterolateral thigh; repeat every 5–15 minutes as needed</li>
          <li>If refractory with impending arrest/shock: IV epinephrine should be reserved for expert use with close monitoring (local protocol/medical direction)</li>
        </ul>
        <p><strong>Severe bradycardia / hypotension (when escalation needed)</strong></p>
        <ul>
          <li>Infusion dosing varies by protocol; titrate to effect if used (local protocol/medical direction)</li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Anaphylaxis and severe allergic reaction with systemic features</li>
          <li>Cardiac arrest per ACLS</li>
          <li>Severe bronchospasm with impending respiratory failure (as per protocol)</li>
          <li>Critical hypotension/bradycardia when other measures insufficient (protocol-dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>In life-threatening anaphylaxis or cardiac arrest: no practical absolute contraindications</li>
          <li>High-risk cautions (especially IV use): ischemic heart disease, significant hypertension, dysrhythmia risk, hyperthyroidism, diabetes, elderly</li>
          <li>Avoid dosing/concentration errors: 1 mg/mL (1:1000) vs 0.1 mg/mL (1:10,000) preparations may both exist in some systems</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Protect from light; do not use if solution is pink/darker than slightly yellow or has precipitate</li>
          <li>IM: mid-anterolateral thigh preferred for absorption (when treating anaphylaxis)</li>
          <li>IV/IO: use only with continuous monitoring and clear indication (ACLS/shock protocols)</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Continuous ECG, BP, SpO2; reassess airway/ventilation frequently</li>
          <li>Watch for tachyarrhythmias, severe hypertension, chest pain/ischemia, tremor/anxiety</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Tachycardia, palpitations, hypertension</li>
          <li>Tremor, anxiety, headache</li>
          <li>Dysrhythmias, myocardial ischemia (risk increases with IV bolus/dose errors)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Label syringes clearly ("EPI 1 mg/mL") to prevent concentration errors</li>
          <li>Prefer IM for anaphylaxis early; reserve IV for impending arrest/shock under protocol</li>
          <li>Use checklists/closed-loop communication during ACLS to avoid timing/dose drift</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <p><strong>Video:</strong></p>
        <ul>
          <li><a href="https://www.youtube.com/watch?v=Q4qKp5JQKp0">Anaphylaxis epinephrine IM technique</a></li>
        </ul>
        <p><strong>Documentation:</strong></p>
        <ul>
          <li><a href="https://pdf.hres.ca/dpd_pm/00061056.PDF">Health Canada product monograph (PDF)</a></li>
          <li><a href="https://handbook.bcehs.ca/drug-monographs/epinephrine/">BC EHS Drug Monograph – Epinephrine</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
